Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: MA NONMETROPOLITAN AREA — October 2026
Nonmetro Massachusetts regulatory pay holds firm as national rates soften.
Regulatory Affairs Specialist pay in nonmetro Massachusetts held flat at $117,500 even as the national median fell to $103,780, while CRA pay here trails the national figure by roughly $30,000.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Franklin County unemployment: 4.1% — Tracks MA statewide rate of 4.3%
- Dukes County unemployment: 2.9% — Lowest in Massachusetts, August 2026
- Regulatory Affairs pay gap: +$13,720 — Metro $117,500 vs national $103,780, widening
- CRA pay gap: -$29,725 — Metro $60,340 vs national $90,065
Key takeaways
Validation Engineer pay sits above national median here.
Metro median of $113,236 against a national figure of $106,478 suggests nonmetro Massachusetts sites are paying a premium to secure manufacturing-adjacent technical talent, consistent with statewide biomanufacturing momentum. Leaders weighing in-house validation capacity versus CDMO partnerships should treat this premium as a cost input, not an anomaly.
Biostatistician compensation is climbing against a flat national trend.
Metro median rose to $146,366, a moderate increase, while the national median held at $131,958. A nonmetro market outpacing national wage movement in a credentialed analytics role may reflect scarcity pricing rather than broad demand growth — worth confirming against actual requisition volume before recalibrating pay bands broadly.
Clinical Research Associate pay gap raises outsourcing questions.
Metro median of $60,340 trails the national median of $90,065 by a wide margin even as national CRA demand stays candidate-driven and experienced-CRA supply remains the binding constraint. Sites unable to close that gap may find CRO partnerships more reliable than direct hires for clinical operations capacity in the near term.
Regulatory Affairs Specialist pay holds steady while national pay softens.
Metro median of $117,500 stayed flat while the national median fell moderately to $103,780, widening the local premium. Persistent local demand for regulatory talent, against a national pullback, is consistent with statewide reports describing regulatory and CMC hiring as the most competitive life sciences roles to fill.
Median advertised pay by role — MA NONMETROPOLITAN AREA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $111,453 | $141,716 | $152,000 | Stable | $130,339 |
| Clinical Research Associate | $51,573 | $60,340 | $60,340 | Stable | $90,065 |
| Lab Technician * | $43,680 | $54,673 | $60,320 | Stable | $47,840 |
| Regulatory Affairs Specialist * | $84,292 | $117,500 | $132,465 | Stable | $103,780 |
| Clinical Data Manager * | $100,353 | $123,031 | $148,892 | Moderate decline | $123,653 |
| Biostatistician * | $107,561 | $146,366 | $160,280 | Moderate increase | $131,958 |
| Validation Engineer * | $95,530 | $113,236 | $123,552 | Stable | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Franklin, Dukes, and Nantucket counties show tight but uneven labor conditions, with Franklin County unemployment at 4.1% tracking the state average and Dukes County at 2.9%, the lowest in Massachusetts, reflecting seasonal tourism dynamics rather than broad-based tightness. Life sciences employers drawing from this nonmetropolitan talent pool compete against a Boston-Cambridge market where scientist concentration runs twice the national rate, pulling specialized candidates toward metro-core salaries and leaving nonmetro sites to absorb commuting-distance competition without matching density of local talent supply.
What it means
Nonmetropolitan Massachusetts sites face a structural disadvantage in attracting regulatory, CMC, and clinical leadership roles that concentrate in Cambridge and Boston submarkets, making build-vs-outsource decisions for specialized functions more consequential here than in metro-core locations. Statewide biomanufacturing stabilization (238 jobs added after two years of decline) signals employers are investing in advanced-modality manufacturing capability, a signal nonmetro sites with facility capacity could leverage if compensation for bioprocess and validation talent keeps pace with metro benchmarks. Organizations should evaluate whether nonmetro-based manufacturing or quality roles are priced to compete with Cambridge-adjacent commuting distance, not just local labor market averages.
Looking ahead
Worth watching: Blueprint Medicines' 229-worker WARN filing in Cambridge and Foghorn Therapeutics' 40% reduction may release regulatory, CMC, and clinical talent into the broader Massachusetts labor pool. Nonmetro employers should watch whether displaced talent is willing to commute or relocate from Cambridge-adjacent markets.
Emerging pressure point: Biomanufacturing added 238 jobs statewide after two years of decline, concentrated in advanced-modality capability. Nonmetro sites with existing facility footprint should assess whether this signals a window to expand in-house manufacturing headcount before competition for bioprocess engineers intensifies further.
Expected: BLS metro-level unemployment and wage data for the nonmetropolitan area will not publish until December 2, leaving a reporting lag. Workforce planning decisions made this month should rely on county-level proxies (Franklin, Dukes) rather than wait on official metro figures.
Potential inflection point: State tax incentives recently delivered $40 million to 38 life sciences companies to create 1,644 jobs, with Insulet among recipients. Watch whether incentive-driven expansion reaches nonmetro counties or remains concentrated in Boston-Cambridge, which would widen the compensation gap further.
Sources
- Bureau of Labor Statistics / USA Facts — Franklin County unemployment at 4.1%, Dukes County at 2.9% in August 2026
- Pre-researched Massachusetts life sciences market notes — Massachusetts biomanufacturing added 238 jobs after two years of decline
- Layoff Atlas — Blueprint Medicines filed WARN notice for 229 workers in Cambridge, effective Oct 9
- Massachusetts life sciences market research notes — 38 life sciences companies received $40 million in tax incentives for 1,644 jobs
- National life sciences labor market research notes — Experienced CRAs remain the hiring bottleneck nationally, not entry-level roles
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.